{"database": "lobbying", "table": "lobbying_activities", "rows": [[1804741, "0c64ed8b-48bb-49f6-a82d-2d6a2dbe8e1a", "1T", "O'NEILL AND ASSOCIATES", 73134, "THE JETT FOUNDATION", 2016, "first_quarter", "MED", "FDA issues. Seeking accelerated approval for breakthrough medical treatments to treat Duchenne Muscular Dystrophy", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 1, "2016-04-11T14:10:35.463000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1804741"], "units": {}, "query_ms": 1.5527919968008064, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}